The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, R. C., Riley, A., Wagner, G., Osterloh, I. H., Kirkpatrick, J., & Mishra, A. (1997) · Urology · doi:10.1016/s0090-4295(97)00238-0 · Cited by 5,849
The American Urological Association Symptom Index for Benign Prostatic Hyperplasia
Barry, M. J., Fowler, F. J., O’Leary, M. P., Bruskewitz, R. C., Holtgrewe, H. L., Mebust, W. K., Cockett, A. T. K., & The Measurement Committee of the American Urological Association (1992) · Journal of Urology · doi:10.1016/s0022-5347(17)36966-5 · Cited by 3,436
Heidenreich, A., Bellmunt, J., Bolla, M., Joniau, S., Mason, M., Matveev, V., Mottet, N., Schmid, H.-P., van der Kwast, T., Wiegel, T., et al. (2011) · European Urology · doi:10.1016/j.eururo.2010.10.039 · Cited by 1,492
Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer
Klotz, L., Vesprini, D., Sethukavalan, P., Jethava, V., Zhang, L., Jain, S., Yamamoto, T., Mamedov, A., & Loblaw, A. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.1192 · Cited by 1,221
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
Thompson, I., Thrasher, J. B., Aus, G., Burnett, A. L., Canby-Hagino, E. D., Cookson, M. S., D’Amico, A. V., Dmochowski, R. R., Eton, D. T., Forman, J. D., et al. (2007) · Journal of Urology · doi:10.1016/j.juro.2007.03.003 · Cited by 1,113
前立腺癌のEAUガイドライン。パート1:臨床的限局性疾患のスクリーニング,診断および治療
Heidenreich, A., Bellmunt, J., Bolla, M., et al. (2011) · European Urology · Cited by 866
Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study
Ahmed, H. U., Hindley, R. G., Dickinson, L., Freeman, A., Kirkham, A. P., Sahu, M., Scott, R., Allen, C., Van der Meulen, J., & Emberton, M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70121-3 · Cited by 397
Self-citationThe Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review
Valerio, M., Ahmed, H. U., Emberton, M., Lawrentschuk, N., Lazzeri, M., Montironi, R., Nguyen, P. L., Trachtenberg, J., & Polascik, T. J. (2014) · European Urology · doi:10.1016/j.eururo.2013.05.048 · Cited by 369
Self-citationGodtman, R. A., Holmberg, E., Khatami, A., Pihl, C.-G., Stranne, J., & Hugosson, J. (2016) · European Urology · doi:10.1016/j.eururo.2016.03.048 · Cited by 163
van den Bergh, R. C. N., Ahmed, H. U., Bangma, C. H., Cooperberg, M. R., Villers, A. A., & Parker, C. C. (2014) · European Urology · doi:10.1016/j.eururo.2014.01.027 · Cited by 125
Cited by
Clinical development and potential of photothermal and photodynamic therapies for cancer
Li, X., Lovell, J. F., Yoon, J., & Chen, X. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0410-2 · Cited by 3,456
Clinical development of photodynamic agents and therapeutic applications
Baskaran, R., Lee, J., & Yang, S.-G. (2018) · Biomaterials Research · doi:10.1186/s40824-018-0140-z · Cited by 564
Clinical Development of Metal Complexes as Photosensitizers for Photodynamic Therapy of Cancer
Karges, J. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202112236 · Cited by 446
Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology?
McFarland, S. A., Mandel, A., Dumoulin-White, R., & Gasser, G. (2020) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.10.004 · Cited by 347
Photodynamic Therapy for Cancer: What's Past is Prologue
Hamblin, M. R. (2020) · Photochemistry and Photobiology · doi:10.1111/php.13190 · Cited by 310
Metadata
- Authors
- Azzouzi, A.-R., Vincendeau, S., Barret, E., Cicco, A., Kleinclauss, F., van der Poel, H. G., Stief, C. G., Rassweiler, J., Salomon, G., Solsona, E., Alcaraz, A., Tammela, T. T., Rosario, D. J., Gomez-Veiga, F., Ahlgren, G., Benzaghou, F., Gaillac, B., Amzal, B., Debruyne, F. M. J., Fromont, G., Gratzke, C., & Emberton, M.
- Venue
- The Lancet Oncology
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 18
- Issue
- 2
- Pages
- 181-191
- ISSN
- 1470-2045 (ISSN-L)
- OpenAlex
- W2566433825
- Cited by
- 342
- References
- 14
- FWCI
- 32.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial. https://app.cochat.ai/papers/10.1016/s1470-2045(16)30661-1
- The paper
- Azzouzi, A.-R., Vincendeau, S., Barret, E., Cicco, A., Kleinclauss, F., van der Poel, H. G., Stief, C. G., Rassweiler, J., Salomon, G., Solsona, E., Alcaraz, A., Tammela, T. T., Rosario, D. J., Gomez-Veiga, F., Ahlgren, G., Benzaghou, F., Gaillac, B., Amzal, B., Debruyne, F. M. J., . . . Emberton, M. (2017). Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(16)30661-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.